Skip to content

Released Oct 28, 2019, after the close

10-Q filed Oct 28, 2019, 28 days after period end · 0001564590-19-038146

Q3 2019 · 10-Q
Revenue$113.50M+1.6% vs Q3 2018−2.0% vs Q2 2019
Net Income-$40.50MN/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$2.14N/M vs Q3 2018N/M vs Q2 2019
Gross Profit$88,603,000+1.0%
Operating Income-$18,882,000N/M
Operating Cash Flowderived$11,746,000−25.6%
Free Cash Flowderived$7,604,000−36.6%
Margins · derived
Gross margin78.1%−0.4 pt vs Q3 2018
Operating margin-16.6%−20.1 pt vs Q3 2018
Net margin-35.7%−34.6 pt vs Q3 2018

What the release said

The release

Same quarter

MetricQ3 2019Q3 2018Q3 2017Q3 2016
Revenue$113.50M$111.71M$105.25M$98.50M
Net Income-$40.50M-$1.21M$3.46M$9.90M
EPS Diluted-$2.14-$0.07$0.19$0.54

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR